147 related articles for article (PubMed ID: 15194473)
1. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J
Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473
[TBL] [Abstract][Full Text] [Related]
2. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
3. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM
Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144
[TBL] [Abstract][Full Text] [Related]
4. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.
Toyoshima H; Nasa Y; Kohsaka Y; Isayama Y; Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):344-52. PubMed ID: 9489624
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla.
Chan SH; Hsu KS; Huang CC; Wang LL; Ou CC; Chan JY
Circ Res; 2005 Oct; 97(8):772-80. PubMed ID: 16151022
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.
Qamirani E; Ren Y; Kuo L; Hein TW
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):995-1001. PubMed ID: 15718491
[TBL] [Abstract][Full Text] [Related]
7. Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells.
Nguyen A; Chen P; Cai H
FEBS Lett; 2004 Aug; 572(1-3):307-13. PubMed ID: 15304367
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
[TBL] [Abstract][Full Text] [Related]
9. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase.
Ungvari Z; Csiszar A; Huang A; Kaminski PM; Wolin MS; Koller A
Circulation; 2003 Sep; 108(10):1253-8. PubMed ID: 12874194
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
Schäfer A; Fraccarollo D; Tas P; Schmidt I; Ertl G; Bauersachs J
Eur J Heart Fail; 2004 Mar; 6(2):151-9. PubMed ID: 14984722
[TBL] [Abstract][Full Text] [Related]
11. Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation.
Lu C; Su LY; Lee RM; Gao YJ
Eur J Pharmacol; 2008 Jul; 589(1-3):188-93. PubMed ID: 18538762
[TBL] [Abstract][Full Text] [Related]
12. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M
J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension.
Ju H; Behm DJ; Nerurkar S; Eybye ME; Haimbach RE; Olzinski AR; Douglas SA; Willette RN
J Pharmacol Exp Ther; 2003 Dec; 307(3):932-8. PubMed ID: 14561851
[TBL] [Abstract][Full Text] [Related]
14. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase.
Sarr M; Chataigneau M; Martins S; Schott C; El Bedoui J; Oak MH; Muller B; Chataigneau T; Schini-Kerth VB
Cardiovasc Res; 2006 Sep; 71(4):794-802. PubMed ID: 16822492
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
[TBL] [Abstract][Full Text] [Related]
18. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
